Landmark TRIC Valve Implantation at Dana Shivam Heart & Superspeciality Hospital, Jaipur by Dr Sunil Garssa

Diagnostic Findings: Severe Valve Regurgitation with Preserved LV Function

Echocardiography revealed:

• Normal left ventricular (LV) function
• Severe tricuspid valve regurgitation
• Near-normal right ventricular (RV) pressures
• Funnel-shaped inferior and superior vena cava (IVC and SVC) — a sign of chronic venous congestion

Minimally Invasive Procedure: Expertise-Driven and Incision-Free

The TRIC valve implantation was performed via the right femoral vein using a completely percutaneous approach — no incision or stitches were required. This advanced intervention demands a high level of expertise, especially given the fragile condition of the patient and the complexity of the tricuspid valve anatomy.

Dr. Sunil Kumar Garssa, who has over 19 years of cardiology experience, emphasized the technical challenges of the case. “These are very high-risk, symptomatic patients. A detailed understanding of anatomy and solid procedural experience is essential,” he stated.

Successful Outcome: Quick Recovery and Discharge

The procedure was uneventful, and the patient made a swift recovery:

• Transferred to general ward the next day
• Discharged shortly thereafter
• Now ambulatory and able to walk independently

About Dr. Sunil Kumar Garssa

Dr. Garssa is renowned for his proficiency in:

• Radial angiography and angioplasty
• Percutaneous interventions for congenital heart disease (e.g., PDA and ASD device closures)
• Complex structural heart disease interventions

He currently serves as Senior Consultant in Cardiology and Director of Cardiac Cath Lab at Dana Shivam Heart & Superspeciality Hospital.

A Model of Innovation and Expertise in Cardiology

This successful TRIC valve implantation demonstrates the hospital’s commitment to cutting-edge cardiac care and underscores Dr. Garssa’s leadership in interventional cardiology. The case represents a beacon of hope for elderly patients with inoperable tricuspid valve disease and severe symptoms.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.